$RVP
RETRACTABLE TECHNOLOGIES INC Stock $rvp

$rvp Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000155837024004361 Filed on March 29, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$7.599M	$14.29M	$43.60M
YoY Change	-30.92%	12.7%	-54.02%
Cost Of Revenue	$5.698M	$12.75M	$34.49M
YoY Change	-29.92%	52.2%	-48.19%
Gross Profit	$1.901M	$1.541M	$9.108M
YoY Change	-33.75%	-64.19%	-67.76%
Gross Profit Margin	25.01%	10.78%	20.89%
Selling, General & Admin	$4.745M	$4.158M	$20.01M
YoY Change	-13.42%	-65.38%	-29.97%
% of Gross Profit	249.6%	269.89%	219.75%
Research & Development	$142.3K	$161.7K	$581.2K
YoY Change	9.64%	36.98%	10.55%
% of Gross Profit	7.48%	10.5%	6.38%
Depreciation & Amortization	$1.889M	$1.697M	$7.527M
YoY Change	-2.55%	4.89%	63.53%
% of Gross Profit	99.4%	110.16%	82.65%
Operating Expenses	$4.887M	$4.320M	$20.60M
YoY Change	-12.89%	-64.38%	-29.24%
Operating Profit	-$2.986M	-$2.779M	-$11.49M
YoY Change	8.97%	-64.49%	1246.84%
Interest Expense	$33.48K	$991.3K	$152.2K
YoY Change	-23.12%	-69.91%	-10.83%
% of Operating Profit
Other Income/Expense, Net	$1.485M	$1.744M	$6.224M
YoY Change	-4.7%	-7.15%	62.39%
Pretax Income	$515.0K	-$43.71K	-$8.916M
YoY Change	-57.85%	-98.35%	-272.71%
Income Tax	$85.59K	$29.23K	-$1.905M
% Of Pretax Income	16.62%
Net Earnings	$429.4K	-$130.6K	-$7.011M
YoY Change	-56.67%	-96.99%	-238.05%
Net Earnings / Revenue	5.65%	-0.91%	-16.08%
Basic Earnings Per Share	$0.01		-$0.24
Diluted Earnings Per Share	$0.01	$0.00	-$0.24
COMMON SHARES
Basic Shares Outstanding	29.94M	29.94M	29.94M
Diluted Shares Outstanding	29.95M		29.94M

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$46.64M	$47.29M	$47.29M
YoY Change	-1.58%	-4.23%	-4.23%
Cash & Equivalents	$10.01M	$12.67M	$12.67M
Short-Term Investments	$36.63M	$34.62M	$34.62M
Other Short-Term Assets	$1.004M	$952.7K	$952.7K
YoY Change	-44.07%	-24.52%	-24.78%
Inventory	$19.49M	$17.58M	$17.58M
Prepaid Expenses
Receivables	$7.425M	$10.67M	$10.67M
Other Receivables	$1.155M	$1.155M	$1.155M
Total Short-Term Assets	$75.71M	$77.65M	$77.65M
YoY Change	-14.46%	-12.57%	-12.57%
LONG-TERM ASSETS
Property, Plant & Equipment	$91.82M	$93.48M	$93.48M
YoY Change	-6.96%	-6.66%	-6.66%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$8.445M	$8.544M	$8.544M
YoY Change	30.71%	27.46%	27.46%
Total Long-Term Assets	$100.3M	$102.0M	$102.0M
YoY Change	-4.64%	-4.52%	-4.52%
TOTAL ASSETS
Total Short-Term Assets	$75.71M	$77.65M	$77.65M
Total Long-Term Assets	$100.3M	$102.0M	$102.0M
Total Assets	$176.0M	$179.7M	$179.7M
YoY Change	-9.13%	-8.17%	-8.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.594M	$4.779M	$4.779M
YoY Change	-51.7%	-25.38%	-25.38%
Accrued Expenses	$2.064M	$2.671M	$2.671M
YoY Change	-29.18%	-24.29%	-24.29%
Deferred Revenue	$485.3K	$201.5K
YoY Change	108.18%	-53.78%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$311.1K	$304.0K	$304.0K
YoY Change	8.06%	6.31%	6.31%
Total Short-Term Liabilities	$6.874M	$9.377M	$9.378M
YoY Change	-33.18%	-22.73%	-22.73%
LONG-TERM LIABILITIES
Long-Term Debt	$1.153M	$1.234M	$1.234M
YoY Change	-21.1%	-19.56%	-19.56%
Other Long-Term Liabilities	$68.29M	$69.77M	$69.77M
YoY Change	-8.26%	-7.54%	-7.54%
Total Long-Term Liabilities	$69.44M	$71.01M	$71.01M
YoY Change	-8.51%	-7.77%	-7.77%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.874M	$9.377M	$9.378M
Total Long-Term Liabilities	$69.44M	$71.01M	$71.01M
Total Liabilities	$76.32M	$80.38M	$80.38M
YoY Change	-11.45%	-9.81%	-9.81%
SHAREHOLDERS EQUITY
Retained Earnings	$39.16M	$38.79M
YoY Change	-16.62%	-15.74%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock	$73.16M	$73.16M
YoY Change	-0.01%	-0.01%
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$99.66M	$99.29M	$99.29M
YoY Change
Total Liabilities & Shareholders Equity	$176.0M	$179.7M	$179.7M
YoY Change	-9.13%	-8.17%	-8.17%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$429.4K	-$130.6K	-$7.011M
YoY Change	-56.67%	-96.99%	-238.05%
Depreciation, Depletion And Amortization	$1.889M	$1.697M	$7.527M
YoY Change	-2.55%	4.89%	63.53%
Cash From Operating Activities	-$2.022M	$1.897M	$2.767M
YoY Change	-45.33%	-81.38%	-83.5%
INVESTING ACTIVITIES
Capital Expenditures	$226.4K	$153.0K	$853.0K
YoY Change	-51.58%	-94.81%	-94.93%
Acquisitions
YoY Change
Other Investing Activities	-$276.3K	-$189.3K	-$9.909M
YoY Change	-96.97%	86.8%	-31.05%
Cash From Investing Activities	-$502.7K	-$352.3K	-$10.76M
YoY Change	-94.76%	-88.45%	-65.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$73.65K		$281.9K
YoY Change	4.47%		-0.73%
Cash From Financing Activities	-131.3K	-138.4K	941.6K
YoY Change	128.65%	-83.35%	-81.14%
NET CHANGE
Cash From Operating Activities	-2.022M	1.897M	2.767M
Cash From Investing Activities	-502.7K	-352.3K	-10.76M
Cash From Financing Activities	-131.3K	-138.4K	941.6K
Net Change In Cash	-2.656M	1.406M	-7.054M
YoY Change	-80.12%	-77.69%	-25.29%
FREE CASH FLOW
Cash From Operating Activities	-$2.022M	$1.897M	$2.767M
Capital Expenditures	$226.4K	$153.0K	$853.0K
Free Cash Flow	-$2.249M	$1.744M	$1.914M
YoY Change	-46.03%	-75.9%	-3189.43%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000946563
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023Q4	us-gaap	Common Stock Value CommonStockValue
CY2022Q4	us-gaap	Common Stock Value CommonStockValue
CY2020Q3	rvp	Technology Investment Agreement Term TechnologyInvestmentAgreementTerm	P10Y
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-16465
CY2023	dei	Entity Registrant Name EntityRegistrantName	Retractable Technologies, Inc
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	75-2599762
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	511 Lobo Lane
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Little Elm
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	TX
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75068-5295
CY2023	dei	City Area Code CityAreaCode	972
CY2023	dei	Local Phone Number LocalPhoneNumber	294-1010
CY2023Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	1376555
CY2022Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	973701
CY2023	dei	Security12b Title Security12bTitle	Common Stock
CY2023	dei	Trading Symbol TradingSymbol	RVP
CY2023	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	15000000
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	29937159
CY2023	dei	Auditor Name AuditorName	Moss Adams LLP
CY2023	dei	Auditor Location AuditorLocation	Dallas, TX
CY2023	dei	Auditor Firm AuditorFirmId	659
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12667550
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19721345
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	10671721
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4835119
CY2022Q4	us-gaap	Receivables Long Term Contracts Or Programs ReceivablesLongTermContractsOrPrograms	2025413
CY2023Q4	rvp	Debt Securities Trading And Equity Securities Fv Ni Current DebtSecuritiesTradingAndEquitySecuritiesFvNiCurrent	34621213
CY2022Q4	rvp	Debt Securities Trading And Equity Securities Fv Ni Current DebtSecuritiesTradingAndEquitySecuritiesFvNiCurrent	29657314
CY2023Q4	us-gaap	Inventory Net InventoryNet	17581368
CY2022Q4	us-gaap	Inventory Net InventoryNet	20684168
CY2023Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	1155077
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	10619835
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	952668
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1266516
CY2023Q4	us-gaap	Assets Current AssetsCurrent	77649597
CY2022Q4	us-gaap	Assets Current AssetsCurrent	88809710
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	93478521
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	100152768
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	8392030
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	6518663
CY2023Q4	us-gaap	Other Assets OtherAssets	152064
CY2022Q4	us-gaap	Other Assets OtherAssets	184524
CY2023Q4	us-gaap	Assets Assets	179672212
CY2022Q4	us-gaap	Assets Assets	195665665
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4779035
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6404925
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	303991
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	285954
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	865105
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	997530
CY2023Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	1417437
CY2022Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	1417937
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	630571
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1992144
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	4802
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	63631
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	9377496
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12135822
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	69773538
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	75459612
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1233519
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1533422
CY2023Q4	us-gaap	Liabilities Liabilities	80384553
CY2022Q4	us-gaap	Liabilities Liabilities	89128856
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	34024304
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	34024304
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29937159
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29937159
CY2023Q4	us-gaap	Additional Paid In Capital Preferred Stock AdditionalPaidInCapitalPreferredStock	73160333
CY2022Q4	us-gaap	Additional Paid In Capital Preferred Stock AdditionalPaidInCapitalPreferredStock	73164501
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	38785559
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	46028541
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	4087145
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	4087145
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	12888678
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	12888678
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	99287659
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	106536809
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	179672212
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	195665665
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	43596926
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	94818938
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	188382454
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	34489115
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	66565655
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	93029933
CY2023	us-gaap	Gross Profit GrossProfit	9107811
CY2022	us-gaap	Gross Profit GrossProfit	28253283
CY2021	us-gaap	Gross Profit GrossProfit	95352521
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5706483
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4544052
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4477651
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	581172
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	525727
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	901381
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14308365
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	24036480
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17378301
CY2023	us-gaap	Operating Expenses OperatingExpenses	20596020
CY2022	us-gaap	Operating Expenses OperatingExpenses	29106259
CY2021	us-gaap	Operating Expenses OperatingExpenses	22757333
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-11488209
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-852976
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	72595188
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1377652
CY2023	rvp	Other Income Technology Agreement OtherIncomeTechnologyAgreement	6223891
CY2022	rvp	Other Income Technology Agreement OtherIncomeTechnologyAgreement	3832747
CY2021	rvp	Other Income Technology Agreement OtherIncomeTechnologyAgreement	425158
CY2023	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	-10521166
CY2022	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	2343359
CY2021	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	513529
CY2023	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	5574792
CY2023	rvp	Interest And Other Income Loss InterestAndOtherIncomeLoss	1446661
CY2022	rvp	Interest And Other Income Loss InterestAndOtherIncomeLoss	9948
CY2021	rvp	Interest And Other Income Loss InterestAndOtherIncomeLoss	266467
CY2023	us-gaap	Interest Expense InterestExpense	152166
CY2022	us-gaap	Interest Expense InterestExpense	170651
CY2021	us-gaap	Interest Expense InterestExpense	227183
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8916197
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5162427
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	74950811
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1905161
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	83870
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18886570
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-7011036
CY2022	us-gaap	Net Income Loss NetIncomeLoss	5078557
CY2021	us-gaap	Net Income Loss NetIncomeLoss	56064241
CY2023	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	231946
CY2022	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	232444
CY2021	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	241703
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7242982
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4846113
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	55822538
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.15
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.65
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.24
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.15
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.63
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29937159
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32896348
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33870819
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29937159
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32961945
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34244699
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	49880125
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	48600
CY2021	us-gaap	Dividends Preferred Stock DividendsPreferredStock	5213591
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3660387
CY2021	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	5270501
CY2021	us-gaap	Net Income Loss NetIncomeLoss	56064241
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	99169261
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	13800
CY2022	us-gaap	Dividends Preferred Stock DividendsPreferredStock	232445
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10125813
CY2022	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	7618177
CY2022	us-gaap	Net Income Loss NetIncomeLoss	5078557
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	106536809
CY2023	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	6168
CY2023	us-gaap	Dividends Preferred Stock DividendsPreferredStock	231946
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-7011036
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	99287659
CY2023	us-gaap	Profit Loss ProfitLoss	-7011036
CY2022	us-gaap	Profit Loss ProfitLoss	5078557
CY2021	us-gaap	Profit Loss ProfitLoss	56064241
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7527227
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4602961
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1257417
CY2023	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	-10521166
CY2022	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	2343359
CY2021	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	513529
CY2023	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	5574792
CY2022	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	-327926
CY2023	us-gaap	Accretion Expense AccretionExpense	9157
CY2022	us-gaap	Accretion Expense AccretionExpense	60115
CY2021	us-gaap	Accretion Expense AccretionExpense	109019
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-970
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-159
CY2023	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-1873367
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	7347171
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-9234628
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	626940
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	322991
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	150000
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	10125813
CY2021	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	3660387
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	175355
CY2023	us-gaap	Other Noncash Income OtherNoncashIncome	6223891
CY2022	us-gaap	Other Noncash Income OtherNoncashIncome	3832747
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1377652
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6463542
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-29701396
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	13877663
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2927445
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	94249
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	10355273
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-313848
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	564496
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	17652
CY2023	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-9464758
CY2022	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	10619886
CY2023	rvp	Increase Decrease In Other Operating Assets Excluding Other Current Assets IncreaseDecreaseInOtherOperatingAssetsExcludingOtherCurrentAssets	-32460
CY2022	rvp	Increase Decrease In Other Operating Assets Excluding Other Current Assets IncreaseDecreaseInOtherOperatingAssetsExcludingOtherCurrentAssets	178850
CY2021	rvp	Increase Decrease In Other Operating Assets Excluding Other Current Assets IncreaseDecreaseInOtherOperatingAssetsExcludingOtherCurrentAssets	-38892
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1625890
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-13999647
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4148128
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	807
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-4269163
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2147705
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-58827
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-4896246
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	594107
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2766848
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	16768128
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	32793499
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	852979
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16830077
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	58366563
CY2023	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	68481490
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	18135191
CY2021	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	4748624
CY2023	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	58572186
CY2022	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	3762454
CY2021	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	75000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10762283
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-31202814
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-63040187
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	281866
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	283933
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	274791
CY2023	rvp	Proceeds From Technology Investment Agreement ProceedsFromTechnologyInvestmentAgreement	2563229
CY2022	rvp	Proceeds From Technology Investment Agreement ProceedsFromTechnologyInvestmentAgreement	14235417
CY2021	rvp	Proceeds From Technology Investment Agreement ProceedsFromTechnologyInvestmentAgreement	52366282
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	13800
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	48600
CY2021	rvp	Payment Of Preferred Stock Redemption Price Payable PaymentOfPreferredStockRedemptionPricePayable	101250
CY2023	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	1101110
CY2022	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	1101110
CY2021	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	1101110
CY2023	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	232445
CY2022	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	252879
CY2021	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	3824311
CY2023	us-gaap	Payments For Repurchase Of Convertible Preferred Stock PaymentsForRepurchaseOfConvertiblePreferredStock	6168
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	7618177
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	5270501
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	941640
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4993118
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	41842919
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-7053795
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-9441568
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	11596231
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19721345
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29162913
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17566682
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12667550
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19721345
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29162913
CY2023	us-gaap	Interest Paid Net InterestPaidNet	161322
CY2022	us-gaap	Interest Paid Net InterestPaidNet	110537
CY2021	us-gaap	Interest Paid Net InterestPaidNet	118163
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-9747329
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	12323857
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	27124342
CY2023	rvp	Preferred Dividends Declared Not Paid In Noncash Investing And Financing Activities PreferredDividendsDeclaredNotPaidInNoncashInvestingAndFinancingActivities	1417437
CY2022	rvp	Preferred Dividends Declared Not Paid In Noncash Investing And Financing Activities PreferredDividendsDeclaredNotPaidInNoncashInvestingAndFinancingActivities	1417937
CY2021	rvp	Preferred Dividends Declared Not Paid In Noncash Investing And Financing Activities PreferredDividendsDeclaredNotPaidInNoncashInvestingAndFinancingActivities	1438371
CY2021	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	30500
CY2022	rvp	Amounts Receivable Under Technology Investment Agreement AmountsReceivableUnderTechnologyInvestmentAgreement	2025413
CY2021	rvp	Amounts Receivable Under Technology Investment Agreement AmountsReceivableUnderTechnologyInvestmentAgreement	5924136
CY2023	rvp	Redemption Price Payable In Noncash Investing And Financing Activities RedemptionPricePayableInNoncashInvestingAndFinancingActivities	6000
CY2022	rvp	Redemption Price Payable In Noncash Investing And Financing Activities RedemptionPricePayableInNoncashInvestingAndFinancingActivities	6000
CY2021	rvp	Redemption Price Payable In Noncash Investing And Financing Activities RedemptionPricePayableInNoncashInvestingAndFinancingActivities	6000
CY2022	rvp	Preferred Stock Repurchase In Noncash Investing And Financing Activities PreferredStockRepurchaseInNoncashInvestingAndFinancingActivities	1091953
CY2021	rvp	Preferred Stock Repurchase In Noncash Investing And Financing Activities PreferredStockRepurchaseInNoncashInvestingAndFinancingActivities	2132948
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 18pt;">Accounting estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 18pt;">The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires Management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from those estimates. The amount reported as a contractual allowance for rebates involves examination of past historical trends related to sales to customers and the related credits issued once contractual obligations of the customers have been met. The establishment of a liability for future claims of rebates against sales in the current period requires that the Company has an understanding of the relevant sales with respect to product categories, sales distribution channels, and the likelihood of contractual obligations being satisfied.</p>
CY2023	rvp	Number Of Products Consigned To Customer NumberOfProductsConsignedToCustomer	0
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	890541
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	675208
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments	0
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	473000
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	297000
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 18pt;">Concentration risks</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 18pt;">The Company’s financial instruments exposed to concentrations of credit risk consist primarily of cash, cash equivalents, certificates of deposit, exchange-traded and closed-end funds, mutual funds, equity securities, and accounts receivable. Cash balances, some of which exceed federally insured limits, are maintained in financial institutions; however, Management believes the institutions are of high credit quality. The majority of accounts receivable are due from companies that are well-established entities. The Company assesses market risk in equity securities through consultation with its outside investment advisors. Management is responsible for directing investment activity based on current economic conditions. Management considers any exposure from concentrations of credit risks to be limited. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 18pt;">The following table reflects our significant customers in 2023, 2022, and 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:45.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:45.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;"></span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:49.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Years Ended December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:45.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;"></span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:45.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Number of significant customers</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td></tr><tr><td style="vertical-align:bottom;width:45.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Aggregate dollar amount of net sales to significant customers</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">25.9 million</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">66.4 million</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">113.7 million</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td></tr><tr><td style="vertical-align:bottom;width:45.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Percentage of net sales to significant customers</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">61.3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">70.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">60.3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 18pt;">The Company manufactures some of its products in Little Elm, Texas, as well as utilizing manufacturers in China. The Company obtained roughly 88.4% of its products in 2023 from its Chinese manufacturers. Purchases from Chinese manufacturers aggregated 91.6% and 92% of products in 2022 and 2021, respectively. In the event that the Company becomes unable to purchase products from its Chinese manufacturers, the Company may need to find an alternate manufacturer for its blood collection set, EasyPoint<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">®</sup> blood collection tube holder with needle, IV catheter, Patient Safe<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">®</sup> syringe, 0.5mL insulin syringe, 0.5mL autodisable syringe, and 2mL, 5mL, and 10mL syringes, and would increase domestic production for the 1mL and 3mL syringes and EasyPoint<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">®</sup> needles. </p>
CY2023	us-gaap	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice	2200000
CY2022	us-gaap	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice	3000000.0
CY2023	rvp	License Revenue Percentage Payable To Patent Owner LicenseRevenuePercentagePayableToPatentOwner	0.50
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	43596926
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	94818938
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	188382454
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	15040
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	65597
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	141435
CY2021	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	232445
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	15040
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	65597
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	373880
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-7011036
CY2022	us-gaap	Net Income Loss NetIncomeLoss	5078557
CY2021	us-gaap	Net Income Loss NetIncomeLoss	56064241
CY2023	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	231946
CY2022	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	232444
CY2021	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	241703
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7242982
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4846113
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	55822538
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29937159
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32896348
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33870819
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29937159
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32961945
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34244699
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.15
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.65
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.24
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.15
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.63
CY2023Q4	rvp	Health Insurance Benefits Self Insurance Threshold Minimum For Individual Claims HealthInsuranceBenefitsSelfInsuranceThresholdMinimumForIndividualClaims	100000
CY2023Q4	rvp	Health Insurance Benefits Self Insurance Threshold For Total Plan Claims HealthInsuranceBenefitsSelfInsuranceThresholdForTotalPlanClaims	1700000
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	4349029
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	4896904
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	13232339
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	15787264
CY2023Q4	us-gaap	Inventory Net InventoryNet	17581368
CY2022Q4	us-gaap	Inventory Net InventoryNet	20684168
CY2023Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	34621213
CY2022Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	29657314
CY2023Q4	us-gaap	Debt Securities Trading And Equity Securities Fv Ni Cost DebtSecuritiesTradingAndEquitySecuritiesFvNiCost	40286064
CY2023Q4	rvp	Debt Securities Trading And Equity Securities Accumulated Gross Unrealized Gain DebtSecuritiesTradingAndEquitySecuritiesAccumulatedGrossUnrealizedGain	126705
CY2023Q4	rvp	Debt Securities Trading And Equity Securities Accumulated Gross Unrealized Loss DebtSecuritiesTradingAndEquitySecuritiesAccumulatedGrossUnrealizedLoss	5791556
CY2023Q4	us-gaap	Trading Securities TradingSecurities	34621213
CY2022Q4	us-gaap	Debt Securities Trading And Equity Securities Fv Ni Cost DebtSecuritiesTradingAndEquitySecuritiesFvNiCost	24800998
CY2022Q4	rvp	Debt Securities Trading And Equity Securities Accumulated Gross Unrealized Gain DebtSecuritiesTradingAndEquitySecuritiesAccumulatedGrossUnrealizedGain	4856316
CY2022Q4	us-gaap	Trading Securities TradingSecurities	29657314
CY2023	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	-10521166
CY2022	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	2343359
CY2021	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	513529
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	133192167
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	132339187
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	39713646
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	32186419
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	93478521
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	100152768
CY2023	us-gaap	Depreciation Depreciation	7527227
CY2022	us-gaap	Depreciation Depreciation	4602961
CY2021	us-gaap	Depreciation Depreciation	1257417
CY2023Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	1376555
CY2022Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	973701
CY2023	rvp	Gross Sales Upon Which Royalties Are Based GrossSalesUponWhichRoyaltiesAreBased	64883761
CY2022	rvp	Gross Sales Upon Which Royalties Are Based GrossSalesUponWhichRoyaltiesAreBased	118742140
CY2021	rvp	Gross Sales Upon Which Royalties Are Based GrossSalesUponWhichRoyaltiesAreBased	226294765
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	201492
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	435916
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	320899
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	254584
CY2023Q4	rvp	Current Portion Of Preferred Stock Repurchase CurrentPortionOfPreferredStockRepurchase	6000
CY2022Q4	rvp	Current Portion Of Preferred Stock Repurchase CurrentPortionOfPreferredStockRepurchase	1097954
CY2023Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	102180
CY2022Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	203690
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	630571
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1992144
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	1537510
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	1819376
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	303991
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	285954
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1233519
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1533422
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	303991
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	332480
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	363205
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	396770
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	141064
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	1537510
CY2021Q2	rvp	Number Of Assembly Lines NumberOfAssemblyLines	2
CY2023Q4	rvp	Long Term Deferred Liability Technology Investment Agreement LongTermDeferredLiabilityTechnologyInvestmentAgreement	69773538
CY2022Q4	rvp	Long Term Deferred Liability Technology Investment Agreement LongTermDeferredLiabilityTechnologyInvestmentAgreement	75459612
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	33734
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1448000
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	20041644
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-65529
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-8711302
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	8079555
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-31795
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-7263302
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	28121199
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1855875
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	3717559
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-6719211
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-17491
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	3629613
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-2515418
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1873366
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	7347172
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-9234629
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1905161
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	83870
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18886570
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4654612
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5053102
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	782234
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	713429
CY2023Q4	rvp	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employees DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployees	13311
CY2023Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	299276
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	159405
CY2023Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	14742111
CY2022Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	15860880
CY2023Q4	rvp	Deferred Tax Assets Capital Losses DeferredTaxAssetsCapitalLosses	188270
CY2022Q4	rvp	Deferred Tax Assets Capital Losses DeferredTaxAssetsCapitalLosses	67962
CY2022Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	24572
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	20679814
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	21879350
CY2023Q4	rvp	Deferred Tax Liabilities Unrealized Gains Losses On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsLossesOnTradingSecurities	-1194734
CY2022Q4	rvp	Deferred Tax Liabilities Unrealized Gains Losses On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsLossesOnTradingSecurities	1028232
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	13199805
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	14049742
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	12005071
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	15077974
CY2023Q4	rvp	Deferred Tax Assets Net Of Deferred Tax Liabilities Before Valuation Allowance DeferredTaxAssetsNetOfDeferredTaxLiabilitiesBeforeValuationAllowance	8674743
CY2022Q4	rvp	Deferred Tax Assets Net Of Deferred Tax Liabilities Before Valuation Allowance DeferredTaxAssetsNetOfDeferredTaxLiabilitiesBeforeValuationAllowance	6801376
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	282713
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	282713
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	8392030
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	6518663
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	283000
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	283000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.008
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.010
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.064
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.055
CY2023	rvp	Effective Income Tax Rate Reconciliation Deferred Tax Assets Valuation Allowance Percent EffectiveIncomeTaxRateReconciliationDeferredTaxAssetsValuationAllowancePercent	-0.002
CY2022	rvp	Effective Income Tax Rate Reconciliation Deferred Tax Assets Valuation Allowance Percent EffectiveIncomeTaxRateReconciliationDeferredTaxAssetsValuationAllowancePercent	0.04
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.108
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.001
CY2023	rvp	Effective Income Tax Rate Reconciliation Limit On Compensation Percent EffectiveIncomeTaxRateReconciliationLimitOnCompensationPercent	-0.002
CY2022	rvp	Effective Income Tax Rate Reconciliation Limit On Compensation Percent EffectiveIncomeTaxRateReconciliationLimitOnCompensationPercent	0.309
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.751
CY2021	rvp	Effective Income Tax Rate Reconciliation Paycheck Protection Program Loan Percent EffectiveIncomeTaxRateReconciliationPaycheckProtectionProgramLoanPercent	-0.004
CY2023	rvp	Effective Income Tax Rate Reconciliation Return To Provision And Other Adjustments Percent EffectiveIncomeTaxRateReconciliationReturnToProvisionAndOtherAdjustmentsPercent	0.001
CY2022	rvp	Effective Income Tax Rate Reconciliation Return To Provision And Other Adjustments Percent EffectiveIncomeTaxRateReconciliationReturnToProvisionAndOtherAdjustmentsPercent	0.037
CY2021	rvp	Effective Income Tax Rate Reconciliation Return To Provision And Other Adjustments Percent EffectiveIncomeTaxRateReconciliationReturnToProvisionAndOtherAdjustmentsPercent	-0.017
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.215
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.016
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.252
CY2023	rvp	Number Of Entitled Shareholders NumberOfEntitledShareholders	90
CY2023	rvp	Contingent Liability Former Shareholders ContingentLiabilityFormerShareholders	1400000
CY2023	rvp	Preferred Stock Number Of Classes Outstanding PreferredStockNumberOfClassesOutstanding	1
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2022Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29937159
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29937159
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	4087145
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	4087145
CY2023Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	377595
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3660387
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10100000
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0
CY2023	rvp	Defined Contribution Plan Employee Service Period DefinedContributionPlanEmployeeServicePeriod	P90D
CY2023	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.88
CY2021	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.02
CY2022	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.02
CY2023	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.02
CY2023	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	240635
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	241398
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	204032
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	43596926
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	94818938
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	188382454
CY2023Q4	us-gaap	Noncurrent Assets NoncurrentAssets	93478521
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	100152768
CY2021Q1	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	1101110
CY2022Q1	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	1101110
CY2023Q1	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	1101110
CY2020Q4	rvp	Convertible Preferred Stock Number Of Common Shares Issued Upon Conversion ConvertiblePreferredStockNumberOfCommonSharesIssuedUponConversion	754000
CY2020Q4	rvp	Unpaid Dividends In Arrears Waived UnpaidDividendsInArrearsWaived	7642049
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001558370-24-004361-index-headers.html	Edgar Link	pending
0001558370-24-004361-index.html	Edgar Link	pending
0001558370-24-004361.txt	Edgar Link	pending
0001558370-24-004361-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tmb-20231231.xsd	Edgar Link	pending
tmb-20231231x10k.htm	Edgar Link	pending
tmb-20231231x10k001.jpg	Edgar Link	pending
tmb-20231231xex31d1.htm	Edgar Link	pending
tmb-20231231xex31d2.htm	Edgar Link	pending
tmb-20231231xex32.htm	Edgar Link	pending
tmb-20231231xex97.htm	Edgar Link	pending
tmb-20231231_lab.xml	Edgar Link	unprocessable
tmb-20231231_pre.xml	Edgar Link	unprocessable
tmb-20231231x10k_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
tmb-20231231_cal.xml	Edgar Link	unprocessable
tmb-20231231_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RVP
RETRACTABLE TECHNOLOGIES INC Stock $rvp

2024 Q1 Form 10-K Financial Statement

#000155837024004361 Filed on March 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RVP RETRACTABLE TECHNOLOGIES INC Stock $rvp

2024 Q1 Form 10-K Financial Statement

#000155837024004361 Filed on March 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RVP
RETRACTABLE TECHNOLOGIES INC Stock $rvp